Risk of myocardial infarction at specific troponin T levels using the parameter predictive value among lookalikes

Ola Hammarsten1, Elvar Theodorsson2, Christian Bjurman1

  • 1Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, The Sahlgrenska Academy at the University of Gothenburg, SE-41345 Gothenburg, Sweden.

Clinical Biochemistry
|September 18, 2016
PubMed

Insights

Clinicians can now estimate myocardial infarction risk at specific cardiac troponin T (cTnT) levels using Predictive Value Among Lookalikes (PAL). This method improves diagnostic precision for chest pain patients, regardless of age.

Area of Science:

  • Biomarker analysis
  • Cardiovascular diagnostics
  • Predictive modeling

Background:

  • Elevated cardiac troponin T (cTnT) indicates heart damage, increasing myocardial infarction likelihood.
  • Current methods lack the ability to estimate myocardial infarction risk at specific cTnT levels for individual patients.

Purpose of the Study:

  • To introduce and validate the Predictive Value Among Lookalikes (PAL) method for estimating myocardial infarction risk.
  • To assess the utility of PAL in conjunction with cTnT levels for clinical decision-making.

Main Methods:

  • PAL utilizes pre-test prevalence, sensitivity, and specificity at adjacent cTnT limits derived from percentiles.
  • This method calculates the pre-test prevalence-adjusted probability of disease between cTnT thresholds.

Main Results:

  • PAL demonstrated acceptable sampling error with large-scale biomarker data (38,945 measurements).
  • Analysis of an emergency room cohort (11,020 patients) showed consistent diagnostic precision of high-sensitive cTnT assays across different age groups.
  • PAL identified that higher myocardial infarction prevalence in older patients counterbalanced false positives, a finding missed by conventional ROC analysis.

Conclusions:

  • The PAL method successfully calculates myocardial infarction risk at specific cTnT levels.
  • PAL can serve as a valuable complement to existing clinical decision limits for cTnT interpretation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
369
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
697
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
401
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K